The Nuclear Medicine Department at Ridley-Tree Cancer Center (now part of Sutter Health) has announced greater capabilities to treat prostate cancer using the injectable radioligand therapy, Pluvicto ...
April 24, 2025 (Santa Barbara, CA) The Nuclear Medicine Department at Ridley-Tree Cancer Center, now part of Sutter Health, announces greater capabilities to treat prostate cancer using the injectable ...
LOS ANGELES & RESTON, Va.--(BUSINESS WIRE)--The Prostate Cancer Foundation (PCF) and Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced a collaboration that will provide funding and ...
Curium’s strategic investment of over €32 million will establish a European production line for 177Lu-PSMA-I&T, a therapeutic ...
A novel theranostic approach that targets RET—a newly identified biomarker for neuroendocrine prostate cancer—enables ...
Schoolcraft Memorial Hospital Director of Nuclear Medicine Therapy Clinic, Dr. Erich Smith, says the Pluvicto therapy is ...
(WISH) — The American Cancer Society reports that about one in eight men will be diagnosed with prostate cancer in their lifetime. The average age of men who get diagnosed is 67. Today, less than 1% ...
Nuclear medicine is being called a new frontier in cancer care, and new research shows potential new uses for it in treating gastric and pancreatic cancers.Nuclear medicine that uses radioactive ...
Recently, the research group led by Dr. Dechao Feng, Lecturer at University College London (UCL) and Distinguished Research Fellow at Zhejiang Provincial People's Hospital, published a review entitled ...
Press releases are posted on Independent.com as a free community service. April 24, 2025 (Santa Barbara, CA) The Nuclear Medicine Department at Ridley-Tree Cancer Center, now part of Sutter Health, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results